Oddity Tech Ltd reported solid income growth in 2025 despite decreasing cash flow, supported by strategic acquisitions and a robust share repurchase plan. The 2023 acquisition of biotechnology firm Revela Inc. enhances its AI-driven cosmetics platform, aiming to fortify product differentiation. However, margin compression and ongoing securities litigation pose operational challenges. With ample liquidity and no debt at year-end 2025, Oddity's future growth depends on successful innovation, margin management, and navigating regulatory headwinds.